Skip to main content
. 2018 Mar 1;391(5):523–536. doi: 10.1007/s00210-018-1483-7

Table 1.

Experimental groups and treatments

Group Surgery Treatment Compound
I Fx Control PBS
II Fx + TxT Control PBS
III Fx + TxT IL-6 inhibition Anti-IL-6
IV Fx + TxT IL-6 inhibition sgp130Fc

Fx fracture, TxT thoracic trauma, PBS phosphate-buffered saline, sgp130Fc soluble glycoprotein 130-Fc fusion protein, anti-IL-6 anti-IL-6 antibody